Description:
Composite Matrix for Bone Repair Application
NJIT Case No. 12-002
Inventors: Tamunotonye Briggs, Treena Arinzeh
Intellectual Property & Development status: Patent Publication No. US 2016-0000974 A1.
US, European and Japan Patent Protection is pending.
NJIT is currently seeking commercial partners for the further development and commercialization of this opportunity.
Technology Brief:
Researchers at New Jersey Institute of Technology in the Department of Physics have invented novel composite fibrous and non-fibrous matrices of biocompatible, bioactive synthetic polymers and ceramics. The composite matrices support bone cell differentiation and can be used alone or with whole bone marrow, isolated mesenchymal stem cells and/or bone grafts for bone repair and bone regeneration.
The published patent is available at https://www.google.com/patents/US20160000974
Inventors Bio:
Treena Arinzeh, professor of biomedical engineering at NJIT, has earned national recognition for her commitment to making adult stem cell therapy a future reality. Her research interests are in stem cell tissue engineering and applied biomaterials, with a focus in the development of functional biomaterials that can accelerate repair utilizing stem cells and other cell types. She develops biomaterial strategies for the repair of bone, cartilage and other related musculoskeletal tissues. Her research interests also include nerve tissue regeneration, specifically spinal cord.
In fall 2004, President Bush awarded Arinzeh the Presidential Early Career Award for Scientists and Engineers, the highest national honor that a young researcher can receive. In 2003, the National Science Foundation also gave Arinzeh its highest honor--a Faculty Early Career Development award that included a $400,000 research grant.
Arinzeh’s most cited work to date, in a paper in the Journal of Bone and Joint Surgery, demonstrated that adult stem cells taken from one person could be implanted in another without being rejected. It was among the most significant findings in stem cell research in the past few years.